The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions.

[1]  S. Thorsen,et al.  A family with reduced plasminogen activator activity in blood associated with recurrent venous thrombosis. , 2009, Scandinavian journal of haematology.

[2]  I. Nilsson,et al.  A family with thromboembolic disease associated with deficient fibrinolytic activity in vessel wall. , 2009, Acta medica Scandinavica.

[3]  B. Furie,et al.  Molecular and cellular biology of blood coagulation. , 1992, The New England journal of medicine.

[4]  H. Büller,et al.  Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. , 1990, The New England journal of medicine.

[5]  P. Sibony,et al.  Protein S deficiency associated with central retinal artery occlusion. , 1990, Archives of ophthalmology.

[6]  L. Pasquale,et al.  Dural sinus thrombosis with abnormalities of protein S and fibrinogen. , 1990, A M A Archives of Ophthalmology.

[7]  G. Coscas,et al.  Increased red blood cell aggregation in retinal vein occlusion , 1990, British journal of haematology.

[8]  D. Tollefsen.  Laboratory Diagnosis of Antithrombin and Heparin Cofactor II Deficiency , 1990, Seminars in thrombosis and hemostasis.

[9]  C. Chesterman,et al.  Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics , 1989, British journal of haematology.

[10]  A. Patz,et al.  Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). , 1989, Ophthalmology.

[11]  J. Brandt,et al.  RELATIONSHIP BETWEEN LUPUS ANTICOAGULANTS AND ANTIBODIES TO PHOSPHOLIPID , 1988, Thrombosis and Haemostasis.

[12]  J. Nishioka,et al.  Plasma protein S activity measured using Protac, a snake venom derived activator of protein C. , 1988, Thrombosis research.

[13]  S. Rahimtoola,et al.  Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease. , 1987, Circulation.

[14]  P. Mannucci,et al.  Laboratory Screening of Inherited Thrombotic Syndromes , 1987, Thrombosis and Haemostasis.

[15]  R. Bertina,et al.  Hereditary Heparin Cofactor II Deficiency and the Risk of Development of Thrombosis , 1987, Thrombosis and Haemostasis.

[16]  D. Smith,et al.  Protein C deficiency: a cause of amaurosis fugax? , 1987, Journal of neurology, neurosurgery, and psychiatry.

[17]  G. Hughes,et al.  Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. , 1986, Archives of internal medicine.

[18]  K. Stocker,et al.  Fast functional protein C assay using Protac, a novel protein C activator. , 1986, Thrombosis research.

[19]  P. Comp,et al.  The regulation of hemostasis: the protein C system. , 1986, The New England journal of medicine.

[20]  F. Kunz,et al.  Retinaler Gefäßverschluß bei Antithrombin III-Mangel , 1985 .

[21]  G. Hughes,et al.  The anticardiolipin syndrome. , 1985, The Journal of rheumatology.

[22]  B. Boneu,et al.  CONSTITUTIONAL HEPARIN CO-FACTOR II DEFICIENCY ASSOCIATED WITH RECURRENT THROMBOSIS , 1985, The Lancet.

[23]  G. Marbet,et al.  ASSOCIATION OF HEREDITARY HEPARIN CO-FACTOR II DEFICIENCY WITH THROMBOSIS , 1985, The Lancet.

[24]  L. Tengborn,et al.  Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. , 1985 .

[25]  C. Esmon,et al.  Familial protein S deficiency is associated with recurrent thrombosis. , 1984, The Journal of clinical investigation.

[26]  B. Dahlbäck.  Interaction Between Vitamin K-Dependent Protein S and the Complement Protein, C4b-Binding Protein , 1984, Seminars in thrombosis and hemostasis.

[27]  R. Bertina,et al.  The Use of a Functional and Immunologic Assay for Plasma Protein C in the Study of the Heterogeneity of Congenital Protein C Deficiency , 1984, Thrombosis and Haemostasis.

[28]  J. Katz,et al.  INHERITED PROTEIN C DEFICIENCY AND COUMARIN-RESPONSIVE CHRONIC RELAPSING PURPURA FULMINANS IN A NEWBORN INFANT , 1983, The Lancet.

[29]  J. Soria,et al.  Plasminogen Paris I: congenital abnormal plasminogen and its incidence in thrombosis. , 1983, Thrombosis research.

[30]  E. Mullaart,et al.  A Simple, Sensitive Spectrophotometric Assay for Extrinsic (Tissue-Type) Plasminogen Activator Applicable to Measurements in Plasma , 1982, Thrombosis and Haemostasis.

[31]  K. Robbins,et al.  Human Plasminogen Variant Chicago III , 1982, Thrombosis and Haemostasis.

[32]  J. Griffin,et al.  Deficiency of protein C in congenital thrombotic disease. , 1981, The Journal of clinical investigation.

[33]  L. Kowal,et al.  Abnormal fibrinolysis in retinal vein occlusion. , 1981, Australian journal of ophthalmology.

[34]  K. Gohchi,et al.  Abnormal plasminogen, a case of recurrent thrombosis. , 1981, Thrombosis research.

[35]  K. Robbins,et al.  Physiological activation of the human fibrinolytic system. Isolation and characterization of human plasminogen variants, Chicago I and Chicago II. , 1979, The Journal of biological chemistry.

[36]  Cosgriff Tm,et al.  Central retinal vein occlusion in a patient with familial antithrombin III deficiency: case report. , 1979, Annals of Ophthalmology.

[37]  Y. Sakata,et al.  Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. , 1978, The Journal of clinical investigation.

[38]  M. Pandolfi,et al.  COAGULATION AND FlBRlNOLYTlC STUDIES IN 23 PATIENTS WITH OCCLUSION OF THE RETINAL VESSELS , 1972, Acta ophthalmologica.

[39]  M. Pandolfi.  Fibrinolytic activity of retinal vessels in man and monkey. , 1967, American journal of ophthalmology.

[40]  Greiner Ac,et al.  Schizophrenia-melanosis: cause or side-effect? , 1965 .

[41]  O. Egeberg.  Inherited Antithrombin Deficiency Causing Thrombophilia , 1965, Thrombosis and Haemostasis.

[42]  C. Greven,et al.  Protein S deficiency and bilateral branch retinal artery occlusion. , 1991, Ophthalmology.

[43]  M. Samama,et al.  Incidence of thromboembolism in association with congenital disorders in coagulation and fibrinolysis. , 1988, Acta chirurgica Scandinavica. Supplementum.

[44]  J. Soria,et al.  CONGENITAL DYSFIBRINOGENEMIA AND THROMBOSIS , 1988 .

[45]  Triplett Da,et al.  Clinical application of a functional assay for protein C. , 1987 .

[46]  A. Neetens,et al.  Bilateral retinal branch vein occlusion in protein C deficiency. , 1987, Bulletin de la Societe belge d'ophtalmologie.

[47]  A. Girolami,et al.  Fibrinolytic behavior in long-standing branch retinal vein occlusion. , 1987, Ophthalmic Research.

[48]  D. Collen.  Report of the Meeting of the Subcommittee on Fibrinolysis, Jerusalem, Israel, June 2,1986 , 1986, Thrombosis and Haemostasis.

[49]  R. Bertina,et al.  Prevalence of protein C (PC) and protein S (PS) deficiency in patients with thrombotic disease , 1986 .

[50]  S. Pizzo,et al.  Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII/von Willebrand's factor. , 1983, The American journal of medicine.

[51]  H. Heidrich,et al.  Retinal vascular occlusion and thrombocyte aggregation. , 1980, Journal of medicine.

[52]  Priluck Ia.  Impending central retinal vein occlusion associated with increased platelet aggregability. , 1979 .

[53]  I. Nilsson,et al.  Plasminogen Activator Release After Venous Occlusion and Infusion of DDAVP , 1977, Thrombosis and Haemostasis.

[54]  R. Sykes.  Letter: Kwashiorkor and tuberculosis. , 1974, Lancet.